CHANDLER SWEETWOOD: Open Payments
NPI 1578261939 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,060 in 40 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $62 · 2025 $3,060
Travel & lodging: $1,699Food & beverage: $1,361
| Company | Payments | Amount |
|---|---|---|
| Impulse Dynamics (USA) Inc. | 8 | $1,228 |
| Abbott Laboratories | 13 | $1,150 |
| Edwards Lifesciences Corporation | 1 | $160 |
| E.R. Squibb & Sons, L.L.C. | 3 | $159 |
| ABIOMED | 2 | $134 |
| Merck Sharp & Dohme LLC | 3 | $47 |
| AngioDynamics, Inc. | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Daiichi Sankyo Inc. | 2 | $30 |
| CVRx, Inc. | 1 | $26 |
Products named: Optimizer, CARDIOMEMS, SAPIEN 3 Ultra RESILIA, CAMZYOS, ALPHAVAC, Kerendia, VERQUVO, INJECTAFER.
Industry payments across OK — which companies pay providers there.
